{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:03:50Z","timestamp":1784559830947,"version":"3.55.0"},"reference-count":72,"publisher":"Bioscientifica","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,23]]},"abstract":"\n Background<\/jats:title>\n Patients with primary hyperparathyroidism (PHPT) often present with nonspecific neuropsychological symptoms, which remain challenging to quantify. While parathyroidectomy (PTx) recently has been recommended for asymptomatic patients, its benefit remains unclear as existing evidence relies on generic health-related quality of life (HRQoL) tools. In contrast, the disease-specific PHPQoL questionnaire offers more sensitive and clinically relevant symptom assessment. This study aims to translate and validate the PHPQoL for Dutch use and to evaluate the effect of PTx on HRQoL in both symptomatic and asymptomatic PHPT patients.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this single-center prospective study, PHPT patients with at least one surgical indication underwent either PTx or conservative treatment based on medical requirement and patient preference. Clinicians classified patients as asymptomatic if no hypercalcemia-related complaints were present. HRQoL questionnaires were assessed using the PHPQoL, SF-36, and EQ-5D questionnaires at inclusion and 3 months after treatment. Statistical significance was set at\n P<\/jats:italic>\n < 0.001.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of the 100 patients included (mean age: 61.5 \u00b1 12.4 years, 77% female), 89 underwent PTx (symptomatic:\n n<\/jats:italic>\n = 47, asymptomatic:\n n<\/jats:italic>\n = 42), and 11 received conservative treatment. The PHPQoL demonstrated strong psychometric properties and correlated well with generic HRQoL questionnaires. Following PTx, mean PHPQoL scores improved from 52.2 to 65.9 (\n P<\/jats:italic>\n < 0.001); in asymptomatic patients, scores rose from 58.3 to 71.7 (\n P<\/jats:italic>\n < 0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The Dutch version of the PHPQoL is a valid and reliable tool for assessing PHPT and demonstrates significant HRQoL improvements following PTx, including in asymptomatic patients, which may be underestimated by generic instruments.<\/jats:p>\n <\/jats:sec>","DOI":"10.1530\/ec-25-0400","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:22:10Z","timestamp":1759141330000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["Validation and implementation of the Dutch PHPQoL for primary hyperparathyroidism"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-5486","authenticated-orcid":true,"given":"Jaimie L H","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Surgery Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0504-3491","authenticated-orcid":true,"given":"Abbey","family":"Schepers","sequence":"additional","affiliation":[{"name":"Department of Surgery Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1865-1165","authenticated-orcid":true,"given":"Jaap F","family":"Hamming","sequence":"additional","affiliation":[{"name":"Department of Surgery Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6127-3048","authenticated-orcid":true,"given":"Lano","family":"Osman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine division Endocrinology Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7052-6436","authenticated-orcid":true,"given":"Susan M","family":"Webb","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Autonoma Barcelona, Endocrinology, Hospital Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU), EndoERN, CIBERER Unit 747, ISCIII, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1009-8653","authenticated-orcid":true,"given":"Lieke","family":"Welling","sequence":"additional","affiliation":[{"name":"Department of Surgery Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-1588","authenticated-orcid":true,"given":"Elizabeth M","family":"Winter","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine division Endocrinology Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-9342","authenticated-orcid":true,"given":"Marieke","family":"Snel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine division Endocrinology Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-127X","authenticated-orcid":true,"given":"Natasha M","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine division Endocrinology Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Nat Rev Dis Primers","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian JP","year":"2016","unstructured":"Bilezikian JP\n, \nCusano NE\n, \nKhan AA\n, et al.\n Primary hyperparathyroidism. Nat Rev Dis Primers 2016 2 16033. (https:\/\/doi.org\/10.1038\/nrdp.2016.33)"},{"key":"bib2","series-title":"Expert Rev Pharmacoecon Outcomes Res","first-page":"113","article-title":"Quality of life in patients with primary hyperparathyroidism","volume":"14","author":"Cipriani C","year":"2014","unstructured":"Cipriani C\n, \nRomagnoli E\n, \nCilli M\n, et al.\n Quality of life in patients with primary hyperparathyroidism. Expert Rev Pharmacoecon Outcomes Res 2014 14 113\u2013121. (https:\/\/doi.org\/10.1586\/14737167.2014.873702)"},{"key":"bib3","series-title":"Am Heart J","first-page":"331","article-title":"Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?","volume":"162","author":"Anderson JL","year":"2011","unstructured":"Anderson JL\n, \nVanwoerkom RC\n, \nHorne BD\n, et al.\n Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011 162 331\u2013339.e2. (https:\/\/doi.org\/10.1016\/j.ahj.2011.05.005)"},{"key":"bib4","series-title":"J Clin Endocrinol Metab","first-page":"3561","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP\n, \nBrandi ML\n, \nEastell R\n, et al.\n Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014 99 3561\u20133569. (https:\/\/doi.org\/10.1210\/jc.2014-1413)"},{"key":"bib5","series-title":"Surgeon","first-page":"5","article-title":"Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population","volume":"8","author":"Leong KJ","year":"2010","unstructured":"Leong KJ\n, \nSam RC\n & \nGarnham AW\n\n. Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population. Surgeon 2010 8 5\u20138. (https:\/\/doi.org\/10.1016\/j.surge.2009.10.005)"},{"key":"bib6","series-title":"Ann Surg","first-page":"642","article-title":"Primary hyperparathyroidism, cognition, and health-related quality of life","volume":"242","author":"Coker LH","year":"2005","unstructured":"Coker LH\n, \nRorie K\n, \nCantley L\n, et al.\n Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 2005 242 642\u2013650. (https:\/\/doi.org\/10.1097\/01.sla.0000186337.83407.ec)"},{"key":"bib7","series-title":"Surgery","first-page":"1006","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study","volume":"146","author":"Pasieka JL","year":"2009","unstructured":"Pasieka JL\n, \nParsons L\n & \nJones J\n\n. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 2009 146 1006\u20131013. (https:\/\/doi.org\/10.1016\/j.surg.2009.10.021)"},{"key":"bib8","series-title":"Langenbecks Arch Surg","first-page":"941","article-title":"Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"395","author":"Gopinath P","year":"2010","unstructured":"Gopinath P\n, \nSadler GP\n & \nMihai R\n\n. Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism. Langenbecks Arch Surg 2010 395 941\u2013946. (https:\/\/doi.org\/10.1007\/s00423-010-0689-z)"},{"key":"bib9","series-title":"Clin Endocrinol","first-page":"196","article-title":"The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism","volume":"76","author":"Kahal H","year":"2012","unstructured":"Kahal H\n, \nAye M\n, \nRigby AS\n, et al.\n The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism. Clin Endocrinol 2012 76 196\u2013200. (https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04197.x)"},{"key":"bib10","series-title":"Endocr Connect","article-title":"Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism","volume":"11","author":"Christensen JW","year":"2022","unstructured":"Christensen JW\n, \nTh\u00f8gersen KF\n, \nJensen LT\n, et al.\n Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism. Endocr Connect 2022 11 e210630. (https:\/\/doi.org\/10.1530\/ec-21-0630)"},{"key":"bib11","series-title":"Br J Surg","first-page":"223","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism","volume":"105","author":"Bannani S","year":"2018","unstructured":"Bannani S\n, \nChristou N\n, \nGu\u00e9rin C\n, et al\n. Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg 2018 105 223\u2013229. (https:\/\/doi.org\/10.1002\/bjs.10739)"},{"key":"bib12","series-title":"Horm Metab Res","first-page":"772","article-title":"Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study","volume":"49","author":"Storvall S","year":"2017","unstructured":"Storvall S\n, \nRyh\u00e4nen EM\n, \nHeiskanen I\n, et al.\n Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study. Horm Metab Res 2017 49 772\u2013777. (https:\/\/doi.org\/10.1055\/s-0043-118347)"},{"key":"bib13","series-title":"JAMA Surg","first-page":"109","article-title":"Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study","volume":"148","author":"Weber T","year":"2013","unstructured":"Weber T\n, \nEberle J\n, \nMesselh\u00e4user U\n, et al.\n Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg 2013 148 109\u2013115. (https:\/\/doi.org\/10.1001\/2013.jamasurg.316)"},{"key":"bib14","series-title":"J Clin Endocrinol Metab","first-page":"3114","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini E","year":"2007","unstructured":"Ambrogini E\n, \nCetani F\n, \nCianferotti L\n, et al.\n Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007 92 3114\u20133121. (https:\/\/doi.org\/10.1210\/jc.2007-0219)"},{"key":"bib15","series-title":"J Clin Endocrinol Metab","first-page":"1687","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev J","year":"2007","unstructured":"Bollerslev J\n, \nJansson S\n, \nMollerup CL\n, et al.\n Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007 92 1687\u20131692. (https:\/\/doi.org\/10.1210\/jc.2006-1836)"},{"key":"bib16","series-title":"J Clin Endocrinol Metab","first-page":"5415","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao DS","year":"2004","unstructured":"Rao DS\n, \nPhillips ER\n, \nDivine GW\n, et al.\n Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004 89 5415\u20135422. (https:\/\/doi.org\/10.1210\/jc.2004-0028)"},{"key":"bib17","series-title":"J Bone Miner Res","first-page":"2293","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian JP","year":"2022","unstructured":"Bilezikian JP\n, \nKhan AA\n, \nSilverberg SJ\n, et al.\n Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 2022 37 2293\u20132314. (https:\/\/doi.org\/10.1002\/jbmr.4677)"},{"key":"bib18","series-title":"J Clin Endocrinol Metab","first-page":"1571","article-title":"Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism","volume":"101","author":"Webb SM","year":"2016","unstructured":"Webb SM\n, \nPuig-Domingo M\n, \nVillabona C\n, et al.\n Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2016 101 1571\u20131578. (https:\/\/doi.org\/10.1210\/jc.2015-3094)"},{"key":"bib19","series-title":"Health Qual Life Outcomes","first-page":"97","article-title":"Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism","volume":"11","author":"Webb SM","year":"2013","unstructured":"Webb SM\n, \nPuig-Domingo M\n, \nVillabona C\n, et al.\n Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism. Health Qual Life Outcomes 2013 11 97. (https:\/\/doi.org\/10.1186\/1477-7525-11-97)"},{"key":"bib20","series-title":"Qual Life Res","first-page":"323","article-title":"A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach","volume":"7","author":"Herdman M","year":"1998","unstructured":"Herdman M\n, \nFox-Rushby J\n & \nBadia X\n\n. A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998 7 323\u2013335. (https:\/\/doi.org\/10.1023\/a:1024985930536)"},{"key":"bib21","series-title":"Med Care","first-page":"473","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware JE Jr","year":"1992","unstructured":"Ware JE Jr\n & \nSherbourne CD\n\n. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 473\u2013483. (https:\/\/doi.org\/10.1097\/00005650-199206000-00002)"},{"key":"bib22","series-title":"Med Care","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware JE Jr.","year":"1995","unstructured":"Ware JE Jr.\n, \nKosinski M\n, \nBayliss MS\n, et al\n. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 1995 33(Supp. 4) AS264-AS279."},{"key":"bib23","series-title":"J Clin Epidemiol","first-page":"1055","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations","volume":"51","author":"Aaronson NK","year":"1998","unstructured":"Aaronson NK\n, \nMuller M\n, \nCohen PD\n, et al.\n Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998 51 1055\u20131068. (https:\/\/doi.org\/10.1016\/s0895-4356(98)00097-3)"},{"key":"bib24","series-title":"Health Policy","first-page":"199","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group\n. EuroQol \u2013 a new facility for the measurement of health-related quality of life. Health Policy 1990 16 199\u2013208. (https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9)"},{"key":"bib25","series-title":"Health Econ","first-page":"1121","article-title":"The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies","volume":"15","author":"Lamers LM","year":"2006","unstructured":"Lamers LM\n, \nMcDonnell J\n, \nStalmeier PF\n, et al.\n The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006 15 1121\u20131132. (https:\/\/doi.org\/10.1002\/hec.1124)"},{"key":"bib26","series-title":"Eur J Health Econ","first-page":"205","article-title":"Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries","volume":"20","author":"Janssen MF","year":"2019","unstructured":"Janssen MF\n, \nSzende A\n, \nCabases J\n, et al.\n Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ 2019 20 205\u2013216. (https:\/\/doi.org\/10.1007\/s10198-018-0955-5)"},{"key":"bib27","series-title":"BMJ","first-page":"572","article-title":"Cronbach\u2019s alpha","volume":"314","author":"Bland JM","year":"1997","unstructured":"Bland JM\n & \nAltman DG\n\n. Cronbach\u2019s alpha. BMJ 1997 314 572. (https:\/\/doi.org\/10.1136\/bmj.314.7080.572)"},{"key":"bib28","series-title":"J Clin Endocrinol Metab","first-page":"3580","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg SJ","year":"2014","unstructured":"Silverberg SJ\n, \nClarke BL\n, \nPeacock M\n, et al.\n Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014 99 3580\u20133594. (https:\/\/doi.org\/10.1210\/jc.2014-1415)"},{"key":"bib29","series-title":"Surgery","first-page":"153","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up)","volume":"141","author":"Caillard C","year":"2007","unstructured":"Caillard C\n, \nSebag F\n, \nMathonnet M\n, et al.\n Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 2007 141 153\u2013159 discussion 9\u201360. (https:\/\/doi.org\/10.1016\/j.surg.2006.12.004)"},{"key":"bib30","series-title":"J Surg Res","first-page":"53","article-title":"Tired of being ignored: fatigue as a presenting symptom in primary hyperparathyroidism","volume":"263","author":"Montgomery KB","year":"2021","unstructured":"Montgomery KB\n, \nFazendin JM\n, \nLindeman B\n, et al.\n Tired of being ignored: fatigue as a presenting symptom in primary hyperparathyroidism. J Surg Res 2021 263 53\u201356. (https:\/\/doi.org\/10.1016\/j.jss.2021.01.029)"},{"key":"bib31","series-title":"BMC Endocr Disord","first-page":"87","article-title":"Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience","volume":"23","author":"Ionova TI","year":"2023","unstructured":"Ionova TI\n, \nBuzanakov DM\n, \nChernikov RA\n, et al.\n Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience. BMC Endocr Disord 2023 23 87. (https:\/\/doi.org\/10.1186\/s12902-023-01344-z)"},{"key":"bib32","series-title":"Ann Endocrinol","first-page":"1","article-title":"Quality of life, mood and sleep quality in patients with primary hyperparathyroidism. Impact of socio-personal and clinical profile","volume":"84","author":"Febrero B","year":"2023","unstructured":"Febrero B\n, \nRuiz-Manzanera JJ\n, \nRos-Madrid I\n, et al.\n Quality of life, mood and sleep quality in patients with primary hyperparathyroidism. Impact of socio-personal and clinical profile. Ann Endocrinol 2023 84 1\u20137. (https:\/\/doi.org\/10.1016\/j.ando.2022.08.003)"},{"key":"bib33","series-title":"Endocr J","first-page":"87","article-title":"The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire","volume":"68","author":"Somuncu E","year":"2021","unstructured":"Somuncu E\n & \nKara Y\n\n. The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire. Endocr J 2021 68 87\u201393. (https:\/\/doi.org\/10.1507\/endocrj.ej20-0417)"},{"key":"bib34","series-title":"World J Surg","first-page":"2197","article-title":"The influence of hyperparathyroidism patient profile on quality of life after parathyroidectomy","volume":"47","author":"Febrero B","year":"2023","unstructured":"Febrero B\n, \nRuiz-Manzanera JJ\n, \nRos-Madrid I\n, et al.\n The influence of hyperparathyroidism patient profile on quality of life after parathyroidectomy. World J Surg 2023 47 2197\u20132205. (https:\/\/doi.org\/10.1007\/s00268-023-07066-6)"},{"key":"bib35","series-title":"JAMA Surg","first-page":"1051","article-title":"Long-term quality of life after parathyroidectomy for primary hyperparathyroidism: a systematic review","volume":"157","author":"Livschitz J","year":"2022","unstructured":"Livschitz J\n, \nYen TWF\n, \nEvans DB\n, et al.\n Long-term quality of life after parathyroidectomy for primary hyperparathyroidism: a systematic review. JAMA Surg 2022 157 1051. (https:\/\/doi.org\/10.1001\/jamasurg.2022.4249)"},{"key":"bib36","series-title":"J Bone Miner Res","first-page":"3","article-title":"Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study)","volume":"36","author":"Pretorius M","year":"2021","unstructured":"Pretorius M\n, \nLundstam K\n, \nHellstr\u00f6m M\n, et al.\n Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study). J Bone Miner Res 2021 36 3\u201311. (https:\/\/doi.org\/10.1002\/jbmr.4199)"},{"key":"bib1","series-title":"Nat Rev Dis Primers","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian JP","year":"2016","unstructured":"Bilezikian JP\n, \nCusano NE\n, \nKhan AA\n, et al.\n Primary hyperparathyroidism. Nat Rev Dis Primers 2016 2 16033. (https:\/\/doi.org\/10.1038\/nrdp.2016.33)"},{"key":"bib2","series-title":"Expert Rev Pharmacoecon Outcomes Res","first-page":"113","article-title":"Quality of life in patients with primary hyperparathyroidism","volume":"14","author":"Cipriani C","year":"2014","unstructured":"Cipriani C\n, \nRomagnoli E\n, \nCilli M\n, et al.\n Quality of life in patients with primary hyperparathyroidism. Expert Rev Pharmacoecon Outcomes Res 2014 14 113\u2013121. (https:\/\/doi.org\/10.1586\/14737167.2014.873702)"},{"key":"bib3","series-title":"Am Heart J","first-page":"331","article-title":"Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?","volume":"162","author":"Anderson JL","year":"2011","unstructured":"Anderson JL\n, \nVanwoerkom RC\n, \nHorne BD\n, et al.\n Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011 162 331\u2013339.e2. (https:\/\/doi.org\/10.1016\/j.ahj.2011.05.005)"},{"key":"bib4","series-title":"J Clin Endocrinol Metab","first-page":"3561","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP\n, \nBrandi ML\n, \nEastell R\n, et al.\n Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014 99 3561\u20133569. (https:\/\/doi.org\/10.1210\/jc.2014-1413)"},{"key":"bib5","series-title":"Surgeon","first-page":"5","article-title":"Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population","volume":"8","author":"Leong KJ","year":"2010","unstructured":"Leong KJ\n, \nSam RC\n & \nGarnham AW\n\n. Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population. Surgeon 2010 8 5\u20138. (https:\/\/doi.org\/10.1016\/j.surge.2009.10.005)"},{"key":"bib6","series-title":"Ann Surg","first-page":"642","article-title":"Primary hyperparathyroidism, cognition, and health-related quality of life","volume":"242","author":"Coker LH","year":"2005","unstructured":"Coker LH\n, \nRorie K\n, \nCantley L\n, et al.\n Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 2005 242 642\u2013650. (https:\/\/doi.org\/10.1097\/01.sla.0000186337.83407.ec)"},{"key":"bib7","series-title":"Surgery","first-page":"1006","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study","volume":"146","author":"Pasieka JL","year":"2009","unstructured":"Pasieka JL\n, \nParsons L\n & \nJones J\n\n. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 2009 146 1006\u20131013. (https:\/\/doi.org\/10.1016\/j.surg.2009.10.021)"},{"key":"bib8","series-title":"Langenbecks Arch Surg","first-page":"941","article-title":"Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"395","author":"Gopinath P","year":"2010","unstructured":"Gopinath P\n, \nSadler GP\n & \nMihai R\n\n. Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism. Langenbecks Arch Surg 2010 395 941\u2013946. (https:\/\/doi.org\/10.1007\/s00423-010-0689-z)"},{"key":"bib9","series-title":"Clin Endocrinol","first-page":"196","article-title":"The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism","volume":"76","author":"Kahal H","year":"2012","unstructured":"Kahal H\n, \nAye M\n, \nRigby AS\n, et al.\n The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism. Clin Endocrinol 2012 76 196\u2013200. (https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04197.x)"},{"key":"bib10","series-title":"Endocr Connect","article-title":"Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism","volume":"11","author":"Christensen JW","year":"2022","unstructured":"Christensen JW\n, \nTh\u00f8gersen KF\n, \nJensen LT\n, et al.\n Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism. Endocr Connect 2022 11 e210630. (https:\/\/doi.org\/10.1530\/ec-21-0630)"},{"key":"bib11","series-title":"Br J Surg","first-page":"223","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism","volume":"105","author":"Bannani S","year":"2018","unstructured":"Bannani S\n, \nChristou N\n, \nGu\u00e9rin C\n, et al\n. Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg 2018 105 223\u2013229. (https:\/\/doi.org\/10.1002\/bjs.10739)"},{"key":"bib12","series-title":"Horm Metab Res","first-page":"772","article-title":"Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study","volume":"49","author":"Storvall S","year":"2017","unstructured":"Storvall S\n, \nRyh\u00e4nen EM\n, \nHeiskanen I\n, et al.\n Surgery significantly improves neurocognition, sleep, and blood pressure in primary hyperparathyroidism: a 3-year prospective follow-up study. Horm Metab Res 2017 49 772\u2013777. (https:\/\/doi.org\/10.1055\/s-0043-118347)"},{"key":"bib13","series-title":"JAMA Surg","first-page":"109","article-title":"Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study","volume":"148","author":"Weber T","year":"2013","unstructured":"Weber T\n, \nEberle J\n, \nMesselh\u00e4user U\n, et al.\n Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg 2013 148 109\u2013115. (https:\/\/doi.org\/10.1001\/2013.jamasurg.316)"},{"key":"bib14","series-title":"J Clin Endocrinol Metab","first-page":"3114","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini E","year":"2007","unstructured":"Ambrogini E\n, \nCetani F\n, \nCianferotti L\n, et al.\n Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007 92 3114\u20133121. (https:\/\/doi.org\/10.1210\/jc.2007-0219)"},{"key":"bib15","series-title":"J Clin Endocrinol Metab","first-page":"1687","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev J","year":"2007","unstructured":"Bollerslev J\n, \nJansson S\n, \nMollerup CL\n, et al.\n Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007 92 1687\u20131692. (https:\/\/doi.org\/10.1210\/jc.2006-1836)"},{"key":"bib16","series-title":"J Clin Endocrinol Metab","first-page":"5415","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao DS","year":"2004","unstructured":"Rao DS\n, \nPhillips ER\n, \nDivine GW\n, et al.\n Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004 89 5415\u20135422. (https:\/\/doi.org\/10.1210\/jc.2004-0028)"},{"key":"bib17","series-title":"J Bone Miner Res","first-page":"2293","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian JP","year":"2022","unstructured":"Bilezikian JP\n, \nKhan AA\n, \nSilverberg SJ\n, et al.\n Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 2022 37 2293\u20132314. (https:\/\/doi.org\/10.1002\/jbmr.4677)"},{"key":"bib18","series-title":"J Clin Endocrinol Metab","first-page":"1571","article-title":"Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism","volume":"101","author":"Webb SM","year":"2016","unstructured":"Webb SM\n, \nPuig-Domingo M\n, \nVillabona C\n, et al.\n Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2016 101 1571\u20131578. (https:\/\/doi.org\/10.1210\/jc.2015-3094)"},{"key":"bib19","series-title":"Health Qual Life Outcomes","first-page":"97","article-title":"Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism","volume":"11","author":"Webb SM","year":"2013","unstructured":"Webb SM\n, \nPuig-Domingo M\n, \nVillabona C\n, et al.\n Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism. Health Qual Life Outcomes 2013 11 97. (https:\/\/doi.org\/10.1186\/1477-7525-11-97)"},{"key":"bib20","series-title":"Qual Life Res","first-page":"323","article-title":"A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach","volume":"7","author":"Herdman M","year":"1998","unstructured":"Herdman M\n, \nFox-Rushby J\n & \nBadia X\n\n. A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 1998 7 323\u2013335. (https:\/\/doi.org\/10.1023\/a:1024985930536)"},{"key":"bib21","series-title":"Med Care","first-page":"473","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware JE Jr","year":"1992","unstructured":"Ware JE Jr\n & \nSherbourne CD\n\n. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 473\u2013483. (https:\/\/doi.org\/10.1097\/00005650-199206000-00002)"},{"key":"bib22","series-title":"Med Care","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware JE Jr.","year":"1995","unstructured":"Ware JE Jr.\n, \nKosinski M\n, \nBayliss MS\n, et al\n. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 1995 33(Supp. 4) AS264-AS279."},{"key":"bib23","series-title":"J Clin Epidemiol","first-page":"1055","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations","volume":"51","author":"Aaronson NK","year":"1998","unstructured":"Aaronson NK\n, \nMuller M\n, \nCohen PD\n, et al.\n Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998 51 1055\u20131068. (https:\/\/doi.org\/10.1016\/s0895-4356(98)00097-3)"},{"key":"bib24","series-title":"Health Policy","first-page":"199","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group\n. EuroQol \u2013 a new facility for the measurement of health-related quality of life. Health Policy 1990 16 199\u2013208. (https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9)"},{"key":"bib25","series-title":"Health Econ","first-page":"1121","article-title":"The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies","volume":"15","author":"Lamers LM","year":"2006","unstructured":"Lamers LM\n, \nMcDonnell J\n, \nStalmeier PF\n, et al.\n The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006 15 1121\u20131132. (https:\/\/doi.org\/10.1002\/hec.1124)"},{"key":"bib26","series-title":"Eur J Health Econ","first-page":"205","article-title":"Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries","volume":"20","author":"Janssen MF","year":"2019","unstructured":"Janssen MF\n, \nSzende A\n, \nCabases J\n, et al.\n Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ 2019 20 205\u2013216. (https:\/\/doi.org\/10.1007\/s10198-018-0955-5)"},{"key":"bib27","series-title":"BMJ","first-page":"572","article-title":"Cronbach\u2019s alpha","volume":"314","author":"Bland JM","year":"1997","unstructured":"Bland JM\n & \nAltman DG\n\n. Cronbach\u2019s alpha. BMJ 1997 314 572. (https:\/\/doi.org\/10.1136\/bmj.314.7080.572)"},{"key":"bib28","series-title":"J Clin Endocrinol Metab","first-page":"3580","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg SJ","year":"2014","unstructured":"Silverberg SJ\n, \nClarke BL\n, \nPeacock M\n, et al.\n Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014 99 3580\u20133594. (https:\/\/doi.org\/10.1210\/jc.2014-1415)"},{"key":"bib29","series-title":"Surgery","first-page":"153","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up)","volume":"141","author":"Caillard C","year":"2007","unstructured":"Caillard C\n, \nSebag F\n, \nMathonnet M\n, et al.\n Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 2007 141 153\u2013159 discussion 9\u201360. (https:\/\/doi.org\/10.1016\/j.surg.2006.12.004)"},{"key":"bib30","series-title":"J Surg Res","first-page":"53","article-title":"Tired of being ignored: fatigue as a presenting symptom in primary hyperparathyroidism","volume":"263","author":"Montgomery KB","year":"2021","unstructured":"Montgomery KB\n, \nFazendin JM\n, \nLindeman B\n, et al.\n Tired of being ignored: fatigue as a presenting symptom in primary hyperparathyroidism. J Surg Res 2021 263 53\u201356. (https:\/\/doi.org\/10.1016\/j.jss.2021.01.029)"},{"key":"bib31","series-title":"BMC Endocr Disord","first-page":"87","article-title":"Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience","volume":"23","author":"Ionova TI","year":"2023","unstructured":"Ionova TI\n, \nBuzanakov DM\n, \nChernikov RA\n, et al.\n Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience. BMC Endocr Disord 2023 23 87. (https:\/\/doi.org\/10.1186\/s12902-023-01344-z)"},{"key":"bib32","series-title":"Ann Endocrinol","first-page":"1","article-title":"Quality of life, mood and sleep quality in patients with primary hyperparathyroidism. Impact of socio-personal and clinical profile","volume":"84","author":"Febrero B","year":"2023","unstructured":"Febrero B\n, \nRuiz-Manzanera JJ\n, \nRos-Madrid I\n, et al.\n Quality of life, mood and sleep quality in patients with primary hyperparathyroidism. Impact of socio-personal and clinical profile. Ann Endocrinol 2023 84 1\u20137. (https:\/\/doi.org\/10.1016\/j.ando.2022.08.003)"},{"key":"bib33","series-title":"Endocr J","first-page":"87","article-title":"The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire","volume":"68","author":"Somuncu E","year":"2021","unstructured":"Somuncu E\n & \nKara Y\n\n. The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire. Endocr J 2021 68 87\u201393. (https:\/\/doi.org\/10.1507\/endocrj.ej20-0417)"},{"key":"bib34","series-title":"World J Surg","first-page":"2197","article-title":"The influence of hyperparathyroidism patient profile on quality of life after parathyroidectomy","volume":"47","author":"Febrero B","year":"2023","unstructured":"Febrero B\n, \nRuiz-Manzanera JJ\n, \nRos-Madrid I\n, et al.\n The influence of hyperparathyroidism patient profile on quality of life after parathyroidectomy. World J Surg 2023 47 2197\u20132205. (https:\/\/doi.org\/10.1007\/s00268-023-07066-6)"},{"key":"bib35","series-title":"JAMA Surg","first-page":"1051","article-title":"Long-term quality of life after parathyroidectomy for primary hyperparathyroidism: a systematic review","volume":"157","author":"Livschitz J","year":"2022","unstructured":"Livschitz J\n, \nYen TWF\n, \nEvans DB\n, et al.\n Long-term quality of life after parathyroidectomy for primary hyperparathyroidism: a systematic review. JAMA Surg 2022 157 1051. (https:\/\/doi.org\/10.1001\/jamasurg.2022.4249)"},{"key":"bib36","series-title":"J Bone Miner Res","first-page":"3","article-title":"Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study)","volume":"36","author":"Pretorius M","year":"2021","unstructured":"Pretorius M\n, \nLundstam K\n, \nHellstr\u00f6m M\n, et al.\n Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study). J Bone Miner Res 2021 36 3\u201311. (https:\/\/doi.org\/10.1002\/jbmr.4199)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/10\/EC-25-0400.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/10\/EC-25-0400.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/10\/EC-25-0400.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:32:46Z","timestamp":1784557966000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":72,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0400","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}